Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Baricitinib was effective in treating both early and late onset alopecia areata.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Rutin may protect against stomach damage caused by sodium valproate.

Upadacitinib effectively treats pyoderma gangrenosum.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

JAK inhibitors show promise for treating various skin diseases.

Tamsulosin increases the risk of floppy iris syndrome during cataract surgery.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.